Keyphrases
Ectopic Expression
100%
Epithelial-mesenchymal Transition
100%
Differentiation Potential
100%
CD44 Expression
100%
Ph+ Leukemia
100%
Twist1
75%
Bone Marrow Microenvironment
50%
Leukemia
50%
Transforming Growth factor-β1 (TGF-β1)
50%
Hematological Malignancies
25%
Gene Expression
25%
Cluster of Differentiation 44 (CD44)
25%
Cell Adhesion
25%
Tyrosine Kinase Activity
25%
Solid Tumors
25%
Worse Prognosis
25%
Transition Process
25%
Cell Migration
25%
Catenin
25%
Cellular Compartments
25%
Extracellular Matrix
25%
Hematopoietic Stem Cells
25%
Bone Remodeling
25%
Cell Surface Receptor
25%
Hypoxic Condition
25%
Soluble Factors
25%
Phorbol 12-myristate 13-acetate
25%
Erythroid Differentiation
25%
Recurrent Disease
25%
Philadelphia Chromosome
25%
Cell Homing
25%
Chromosome 9
25%
Chromosome 22
25%
Tumor-promoting
25%
Leukemic Stem Cells
25%
Imatinib
25%
Gene Differentiation
25%
Protein Display
25%
Differentiation Capacity
25%
Epithelial Tumor
25%
Reciprocal Translocation
25%
Adhesion Cell
25%
Neoplastic Transformation
25%
Bone Marrow Niche
25%
CD44 Gene
25%
Megakaryocyte Differentiation
25%
BCR-ABL Fusion Gene
25%
Expression Ability
25%
Biochemistry, Genetics and Molecular Biology
Ectopic Expression
100%
CD44
100%
Mesenchymal-Epithelial Transition
80%
TGF Beta 1
40%
Surface Property
20%
Tyrosine Kinase
20%
Stem Cell
20%
Cell Adhesion
20%
Cell Migration
20%
Bone Remodeling
20%
Philadelphia Chromosome
20%
Imatinib
20%
Gene Expression
20%
Cell Homing
20%
Chromosome 22
20%
Chromosome 9
20%
Reciprocal Chromosome Translocation
20%
Fusion Protein
20%
Receptor Tyrosine Kinase
20%
Eicosanoid Receptor
20%
Myristic Acid
20%
Catenin
20%
Hematopoietic Stem Cell
20%
Megakaryocyte
20%
Pharmacology, Toxicology and Pharmaceutical Science
Leukemia
100%
Transforming Growth Factor Beta1
33%
12-O-Tetradecanoylphorbol-13-Acetate
16%
Recurrent Disease
16%
Receptor
16%
Protein Tyrosine Kinase
16%
Hematologic Malignancy
16%
Solid Malignant Neoplasm
16%
Catenin
16%
Philadelphia 1 Chromosome
16%
Fusion Protein
16%
Epithelium Tumor
16%
Reciprocal Chromosome Translocation
16%
Neoplasm
16%
Imatinib
16%